Notice of Change to HEAL Initiative: Announcement of Collaboration Opportunities for Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose (NOT-TR-19-018)

Notice Number: NOT-TR-19-025

Key Dates
Release Date: July 05, 2019

Related Announcements
NOT-TR-19-018

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to change the Eligible Organizations and Information for Foreign Institutions for HEAL Initiative: Announcement of Collaboration Opportunities for Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose NOT-TR-19-018.

Currently Reads:

SUBMISSION AND FUNDING INFORMATION

Proposal submission is a two-step process. Potential collaborators submit a 2-page pdf pre-proposal to the email address below to allow NCATS scientists to determine if the proposed project fits with the goals of the Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose program and the NCATS laboratories’ capabilities.

The NCATS DPI operational model is built on collaboration among components of NIH and external partners. Collaborators bring actionable existing data and disease knowledge to the collaboration, but lack either the expertise or resources to enable discovery. In-kind support will be provided by the NCATS laboratories/programs.

ELIGIBLE ORGANIZATIONS

Public/State Controlled Institution of Higher Education

Private Institution of Higher Education

Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)

Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education)

Small business

Eligible Agencies of the Federal Government, including NIH intramural laboratories

FOREIGN INSTITUTIONS

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Prospective collaborators are encouraged to review the technical assistance slide deck available at https://ncats.nih.gov/heal/intramural-capabilities. Additional information about this collaboration opportunity will be available at: https://ncats.nih.gov/heal/funding.

Revised to read:

SUBMISSION AND FUNDING INFORMATION

Proposal submission is a two-step process. Potential collaborators submit a 2-page pdf pre-proposal to the email address below to allow NCATS scientists to determine if the proposed project fits with the goals of the Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose program and the NCATS laboratories’ capabilities.

The NCATS DPI operational model is built on collaboration among components of NIH and external partners. Collaborators bring actionable existing data and disease knowledge to the collaboration, but lack either the expertise or resources to enable discovery. In-kind support will be provided by the NCATS laboratories/programs.

ELIGIBLE ORGANIZATIONS

Public/State Controlled Institution of Higher Education

Private Institution of Higher Education

Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)

Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education)

Small business

For-Profit Organizations (Other than Small Businesses)

Eligible Agencies of the Federal Government, including NIH intramural laboratories

FOREIGN INSTITUTIONS

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Prospective collaborators are encouraged to review the technical assistance slide deck available at https://ncats.nih.gov/heal/intramural-capabilities. Additional information about this collaboration opportunity will be available at: https://ncats.nih.gov/heal/funding.

Inquiries

Please direct all inquiries to:

Steven Pittenger, PhD

National Center for Advancing Translational Sciences (NCATS)

Email: NCATSDPIHEALCollab@nih.gov